Platelet-derived serotonin links vascular disease and tissue fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Vascular damage and platelet activation are associated with tissue remodeling in diseases such as systemic sclerosis, but the molecular mechanisms underlying this association have not been identified. In this study, we show that serotonin (5-hydroxytryptamine [5-HT]) stored in platelets strongly induces extracellular matrix synthesis in interstitial fibroblasts via activation of 5-HT2B receptors (5-HT2B) in a transforming growth factor β (TGF-β)–dependent manner. Dermal fibrosis was reduced in 5-HT2B−/− mice using both inducible and genetic models of fibrosis. Pharmacologic inactivation of 5-HT2B also effectively prevented the onset of experimental fibrosis and ameliorated established fibrosis. Moreover, inhibition of platelet activation prevented fibrosis in different models of skin fibrosis. Consistently, mice deficient for TPH1, the rate-limiting enzyme for 5-HT production outside the central nervous system, showed reduced experimental skin fibrosis. These findings suggest that 5-HT/5-HT2B signaling links vascular damage and platelet activation to tissue remodeling and identify 5-HT2B as a novel therapeutic target to treat fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. 5-HT2B is overexpressed in patients with SSc. (A) 5-HT2B was detectable by immunohistochemistry in fibroblasts, keratinocytes, and microvessels of SSc patients and controls. Two representative tissue sections and an isotype control are shown. (B) 5-HT2B expression in SM22-α–negative and α-SMA–positive myofibroblasts. A representative skin section of an SSc patient is shown. SM22-α as specific marker for vascular smooth muscle cells was stained with DAB, the myofibroblast marker α-SMA with Alexa Flour 594 (red), and 5-HT2B with Alexa Flour 488 (green; n = 8 each). The stainings were performed in three independent series. Bars: (A and B [top]) 50 µm; (B, bottom) 10 µm.](https://figures.cochat.ai/paper-figures/2d4bce77e10e467e91ca2a569232e136/platelet-derived-serotonin-links-vascular-disease-and-tissue-fibrosis-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mice that lack this receptor (5H-T2b-/-) are protected against bleomycin-induced skin fibrosis, just as mice in which the 5H-T2b, receptor is pharmacologically inhibited (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“This effect runs via the 5H-T2b receptor; inhibition of this receptor with terguride decreases collagen and fibronectin production by fibroblasts.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“More recently, it was demonstrated that serotonin directly increases extracellular matrix production in primary skin fibroblasts (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840 · cited 1×
“To detect also highly cross-linked collagen, the collagen content in skin samples was analyzed by determination of the hydroxyproline content ( Woessner, 1961 ).”
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312 · cited 1×
“Nuclear and cytoplasmic extracts were prepared as previously described ( Andrews and Faller, 1991 ; Khelifi et al., 2005 ).”
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J.-U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bader, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,570 · cited 4×
“TPH1 # / # mice and 5-HT2B # / # mice have been described previously ( Nebigil et al., 2000 ; Walther et al., 2003b ).”
InfluentialChanges in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472 · cited 1×
“…fibrotic diseases such as systemic sclerosis (SSc) and organ-specific fibrosis such as kidney fibrosis, idiopathic pulmonary fibrosis, and liver cirrhosis share common pathophysiological mechanisms (Bataller and Brenner, 2005; Varga and Abraham, 2007; Strieter and Mehrad, 2009).”
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Research works printed but not linked: 1
- von Werner, 1989, Therapy with terguride, Nichidoku-Iho., 33, 189
Cited by
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843
Self-citationShared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Self-citationUnderstanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Palumbo-Zerr, K., Zerr, P., Distler, A., Fliehr, J., Mancuso, R., Huang, J., Mielenz, D., Tomcik, M., Fürnrohr, B. G., Scholtysek, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3777 · Cited by 342
Self-citationThe pathogenesis, diagnosis and treatment of Raynaud phenomenon
Herrick, A. L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.96 · Cited by 302
Targeting TGF-β signaling for the treatment of fibrosis
Györfi, A. H., Matei, A.-E., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 274
Self-citationHundelshausen, P. V., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 271
Autophagy regulates TNFα-mediated joint destruction in experimental arthritis
Lin, N.-Y., Beyer, C., Gießl, A., Kireva, T., Scholtysek, C., Uderhardt, S., Munoz, L. E., Dees, C., Distler, A., Wirtz, S., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201671 · Cited by 269
“Quantitative real-time PCR Gene expression was quantified by SYBR Green real-time PCR as described.(24) The following primer pairs were used: mouse cathepsin K: 50-GGAAGAAGACTCACCAGAAGC-30 and 50-GT CATATAGCCGCCTCCACAG-30; mouse TRAP 50-CGACCATT GTTAGCCACATACG-30 and 50-TCGTCCTGAAGATACTGCAG GTT-30; mouse OSCAR 50-TCGC…”
MethodSelf-citationBarnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Self-citationLaidlaw, T. M., Kidder, M. S., Bhattacharyya, N., Xing, W., Shen, S., Milne, G. L., Castells, M. C., Chhay, H., & Boyce, J. A. (2012) · Blood · doi:10.1182/blood-2011-10-384826 · Cited by 248
“Median age, y (range) 45 (20-65) 37 (22-76) 34 (22-52)”
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Shi, X., Young, C. D., Zhou, H., & Wang, X.-J. (2020) · Biomolecules · doi:10.3390/biom10121666 · Cited by 243
Gut-Derived Serotonin Is a Multifunctional Determinant to Fasting Adaptation
Sumara, G., Sumara, O., Kim, J. K., & Karsenty, G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.014 · Cited by 224
“…serotonin is amultifunctional neurotransmitter, gut-derived serotonin (GDS) has emerged recently as a hormone able to regulate bone formation, erythropoiesis, and regenerative processes (Amireault et al., 2011; Dees et al., 2011; Fligny et al., 2008; Lesurtel et al., 2006; Yadav et al., 2008).”
BackgroundPlatelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis
Maugeri, N., Capobianco, A., Rovere-Querini, P., Ramirez, G. A., Tombetti, E., Valle, P. D., Monno, A., D’Alberti, V., Gasparri, A. M., Franchini, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3089 · Cited by 211
β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis
Beyer, C., Schramm, A., Akhmetshina, A., Dees, C., Kireva, T., Gelse, K., Sonnylal, S., de Crombrugghe, B., Taketo, M. M., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200568 · Cited by 203
Self-citationHuang, J., Beyer, C., Palumbo-Zerr, K., Zhang, Y., Ramming, A., Distler, A., Gelse, K., Distler, O., Schett, G., Wollin, L., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207109 · Cited by 196
Self-citationThe immunopathogenesis of fibrosis in systemic sclerosis
Brown, M., & O’Reilly, S. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13238 · Cited by 190
Weyrich, A. S., & Zimmerman, G. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183752 · Cited by 188
“Recent studies utilizing mouse models identified serotonin from platelets as a mediator that links vascular damage to extravascular tissue fibrosis (120), and there is evidence for serotonin Weyrich and Zimmerman Page 12”
BackgroundPU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
“(i) Bleomycin-induced skin fibrosis was induced by local injections of bleomycin at a concentration of 0.5 mg/ml in defined areas of 1cm 2 at the upper back every other day for 4 weeks (6 weeks of age, mixed genders) 77 .”
InfluentialSelf-citationHuang, J., Maier, C., Zhang, Y., Soare, A., Dees, C., Beyer, C., Harre, U., Chen, C.-W., Distler, O., Schett, G., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210823 · Cited by 182
Self-citationThe Platelet Response to Tissue Injury
Eisinger, F., Patzelt, J., & Langer, H. F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00317 · Cited by 154
“This is consistent with the results of a study on platelet induced fibrosis, which indicated that platelet released serotonin stimulates extracellular matrix production in fibroblasts (196).”
ResultSerotonin: A Potent Immune Cell Modulator in Autoimmune Diseases
Wan, M., Ding, L., Wang, D., Han, J., & Gao, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00186 · Cited by 175
Dees, C., Tomcik, M., Palumbo‐Zerr, K., Distler, A., Beyer, C., Lang, V., Horn, A., Zerr, P., Zwerina, J., Gelse, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34500 · Cited by 148
“Immunohistochemical analysis of paraffin-embedded sections was performed as previously described (16).”
Self-citationVettori, S., Gay, S., & Distler, O. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010130 · Cited by 172
“Supported by a grant from the EULAR ODP program.”
MethodSelf-citationTGF-β–induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis
Dees, C., Pötter, S., Zhang, Y., Bergmann, C., Zhou, X., Luber, M., Wohlfahrt, T., Karouzakis, E., Ramming, A., Gelse, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci122462 · Cited by 171
“Cell culture Fibroblasts were prepared by outgrowth of skin biopsies and cultured as described (69-71).”
MethodSelf-citationVitamin D receptor regulates TGF-β signalling in systemic sclerosis
Zerr, P., Vollath, S., Palumbo‐Zerr, K., Tomčík, M., Huang, J., Distler, A., Beyer, C., Dees, C., Gela, K., Distler, O., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204378 · Cited by 170
Self-citationSimultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis
Noda, S., Asano, Y., Nishimura, S., Taniguchi, T., Fujiu, K., Manabe, I., Nakamura, K., Yamashita, T., Saigusa, R., Akamata, K., et al. (2014) · Nature Communications · doi:10.1038/ncomms6797 · Cited by 163
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomcik, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34444 · Cited by 160
Self-citationSirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
Zerr, P., Palumbo‐Zerr, K., Huang, J., Tomčík, M., Šumová, B., Distler, O., Schett, G. A., & Distler, J. H. W. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205740 · Cited by 159
Self-citationGiornale italiano di Dermatologia e Venereologia
Ribero, S., Quaglino, P., Sanlorenzo, M., Osella‐Abate, S., Marenco, F., Fierro, M. T., & Bernengo, M. G. (2012) · Institutional Research Information System University of Turin (University of Turin) · Cited by 155
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Rieder, F., Nagy, L. E., Maher, T. M., Distler, J. H. W., Kramann, R., Hinz, B., & Prunotto, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01158-9 · Cited by 150
Self-citationZehender, A., Huang, J., Györfi, A.-H., Matei, A.-E., Trinh-Minh, T., Xu, X., Li, Y.-N., Chen, C.-W., Lin, J., Dees, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05768-3 · Cited by 126
Self-citationBeyer, C., Zenzmaier, C., Palumbo‐Zerr, K., Mancuso, R., Distler, A., Dees, C., Zerr, P., Huang, J., Maier, C., Pachowsky, M. L., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204508 · Cited by 139
Self-citationNear-Infrared Imaging of Serotonin Release from Cells with Fluorescent Nanosensors
Dinarvand, M., Neubert, E., Meyer, D., Selvaggio, G., Mann, F. A., Erpenbeck, L., & Kruss, S. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02865 · Cited by 138
Transporters in human platelets: physiologic function and impact for pharmacotherapy
Jedlitschky, G., Greinacher, A., & Kroemer, H. K. (2012) · Blood · doi:10.1182/blood-2011-09-336933 · Cited by 121
“Recently, it was also shown that serotonin strongly induces extracellular matrix synthesis in interstitial fibroblasts and promotes tissue fibrosis.(71) Serotonin storage in platelets results from a two-step process: first, the uptake across the platelet plasma membrane, and second, the transport across the dense gran…”
BackgroundBlockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Beyer, C., Reichert, H., Akan, H., Mallano, T., Schramm, A., Dees, C., Palumbo-Zerr, K., Lin, N. Y., Distler, A., Gelse, K., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202544 · Cited by 114
Self-citationPeripheral Serotonin Synthesis as a New Drug Target
Matthes, S., & Bader, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.03.004 · Cited by 113
“Furthermore, 5-HT2A/B receptor antagonists exert antifibrotic effects in the same [94,96] and other animal models of tissue fibrosis [95,97].”
BackgroundInactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss
Lin, N.-Y., Chen, C.-W., Kagwiria, R., Liang, R., Beyer, C., Distler, A., Luther, J., Engelke, K., Schett, G., & Distler, J. H. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207240 · Cited by 123
Self-citationCellular and molecular mechanisms in fibrosis
Dees, C., Chakraborty, D., & Distler, J. H. W. (2020) · Experimental Dermatology · doi:10.1111/exd.14193 · Cited by 121
Self-citationTissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies
Lemos, D. R., & Duffield, J. S. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5174 · Cited by 113
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
Zehender, A., Li, Y., Lin, N., Stefanica, A., Nüchel, J., Chen, C., Hsu, H.-H., Zhu, H., Ding, X., Huang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24601-y · Cited by 118
Self-citationMaier, C., Ramming, A., Bergmann, C., Weinkam, R., Kittan, N. A., Schett, G. A., Distler, J. H. W., & Beyer, C. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210189 · Cited by 116
Self-citationJiang, D., & Scharffetter‐Kochanek, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00697 · Cited by 116
Habets, K. L. L., Huizinga, T. W. J., & Toes, R. E. M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12101 · Cited by 114
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Tomčík, M., Zerr, P., Pitkowski, J., Palumbo‐Zerr, K., Avouac, J., Distler, O., Bečvář, R., Šenolt, L., Schett, G. A., & Distler, J. H. W. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203095 · Cited by 111
Self-citationInhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Krämer, M., Dees, C., Huang, J., Schlottmann, I., Palumbo-Zerr, K., Zerr, P., Gelse, K., Beyer, C., Distler, A., Marquez, V. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201615 · Cited by 109
Self-citationSerotonin paracrine signaling in tissue fibrosis
Mann, D. A., & Oakley, F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.009 · Cited by 109
“gov/pmc/articles/PMC3793867/?report=printable 10/19 HT in scleroderma [72].”
Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets
Scherlinger, M., Guillotin, V., Truchetet, M., Contin‐Bordes, C., Sisirak, V., Duffau, P., Lazaro, E., Richez, C., & Blanco, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.012 · Cited by 107
Systemic sclerosis and localized scleroderma—current concepts and novel targets for therapy
Distler, O., & Cozzio, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0551-z · Cited by 104
“fibrotic effects via 5-HT2B receptors on dermal fibroblasts [31].”
BackgroundSelf-citationMaugeri, N., Rovere, P. Q., Baldini, M., Baldissera, E. M., Sabbadini, M. G., Bianchi, M. E., & Manfredi, A. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5298 · Cited by 100
“They release VEGF, which targets endothelial cells (69), and an array of potentially profibrotic agents, such as transforming growth factor-b, platelet-derived growth factor, and serotonin (16).”
Wang, Y., Hsu, Y., Wu, H.-F., Lee, G.-L., Yang, Y., Wu, J.-Y., Yet, S., Wu, K. K., & Kuo, C.-C. (2016) · Circulation Research · doi:10.1161/circresaha.116.308559 · Cited by 99
Inhibition of serotonin synthesis: A novel therapeutic paradigm
Bäder, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107423 · Cited by 96
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Distler, A., Deloch, L., Huang, J., Dees, C., Lin, N.-Y., Palumbo-Zerr, K., Beyer, C., Weidemann, A., Distler, O., Schett, G., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202275 · Cited by 89
“MATERIAL AND METHODS Experimental models of dermal fibrosis Bleomycin-induced dermal fibrosis was modelled as described.(13) 14 In a second model, fibrosis was induced by intradermal injections of replicationdeficient type 5 adenoviruses encoding for a constitutively active TGF-β receptor type I mutant (Ad-TBRI).”
MethodSelf-citationSecrets of platelet exocytosis – what do we really know about platelet secretion mechanisms?
Golebiewska, E. M., & Poole, A. W. (2013) · British Journal of Haematology · doi:10.1111/bjh.12682 · Cited by 93
Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
Distler, J. H. W., Feghali‐Bostwick, C., Soare, A., Asano, Y., Distler, O., & Abraham, D. J. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39865 · Cited by 82
“Mice deficient in 5-HT2B are protected from the development of experimental skin fibrosis (7).”
BackgroundSelf-citationStimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Beyer, C., Reich, N., Schindler, S. C., Akhmetshina, A., Dees, C., Tomčík, M., Hirth‐Dietrich, C., von Degenfeld, G., Sandner, P., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200862 · Cited by 90
Self-citationHorn, A., Kireva, T., Palumbo‐Zerr, K., Dees, C., Tomčík, M., Cordazzo, C., Zerr, P., Akhmetshina, A., Ruat, M., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200883 · Cited by 89
Self-citationS100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
Tomčík, M., Palumbo‐Zerr, K., Zerr, P., Avouac, J., Dees, C., Šumová, B., Distler, A., Beyer, C., Cerezo, L. A., Bečvář, R., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204516 · Cited by 85
Self-citationImmune cell dysregulation as a mediator of fibrosis in systemic sclerosis
Fang, D., Chen, B., Lescoat, A., Khanna, D., & Mu, R. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00864-7 · Cited by 84
Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle
Dehghani, T., & Panitch, A. (2020) · Open Biology · doi:10.1098/rsob.200161 · Cited by 81
“The reparative action by myofibroblasts in response to matrix degradation leads to the formation of a dense, disorganized fibrotic tissue [124].”
BackgroundDomínguez‐Soto, Á., Usategui, A., Casas-Engel, M. D. L., Simón‐Fuentes, M., Nieto, C., Cuevas, V. D., Vega, M. A., Pablos, J. L., & Corbí, A. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-15348-y · Cited by 76
Zerr, P., Palumbo‐Zerr, K., Distler, A., Tomčík, M., Vollath, S., Munoz, L. E., Beyer, C., Dees, C., Egberts, F., Tinazzi, I., et al. (2012) · Blood · doi:10.1182/blood-2012-01-403428 · Cited by 74
Self-citationPulmonary Arterial Hypertension in Connective Tissue Diseases
Mathai, S. C., & Hassoun, P. M. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.04.001 · Cited by 73
“In SSc, the pathogenic implication of 5-HT signalling pathways has only recently been studied in detail [143].”
BackgroundHarifi, G., & Sibilia, J. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.4.14768 · Cited by 73
Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis
Dolivo, D., Larson, S. A., & Dominko, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2880-2 · Cited by 73
Dees, C., Beyer, C., Distler, A., Soare, A., Zhang, Y., Palumbo‐Zerr, K., Distler, O., Schett, G. A., Sandner, P., & Distler, J. H. W. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206809 · Cited by 72
Self-citationAutocrine and paracrine regulatory functions of platelet serotonin
Mammadova‐Bach, E., Mauler, M., Braun, A., & Duerschmied, D. (2018) · Platelets · doi:10.1080/09537104.2018.1478072 · Cited by 72
“showed that cultured dermal fibroblasts from systemic scleroderma patients respond to 5-HT by enhancing the expression of collagen Ia1, collagen Ia2 and fibronectin and subsequent activation of TGF-β signaling (74).”
BackgroundReich, N., Tomcik, M., Zerr, P., Lang, V., Dees, C., Avouac, J., Palumbo, K., Horn, A., Akhmetshina, A., Beyer, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200412 · Cited by 60
Self-citationMean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis
Soydinç, S., Türkbeyler, İ. H., Pehlivan, Y., Soylu, G., Goktepe, F., Bilici, M. F., Zengin, O., Kısacık, B., & Onat, A. M. (2013) · Inflammation · doi:10.1007/s10753-013-9716-x · Cited by 70
“In SSc, the role of platelet-derived serotonin in skin fibrosis is strongly suggested by the stimulation of the production of ECM by serotonin through binding to the dermal fibroblast serotonin receptor 5-HT2B, increased expression of 5-HT2B in the fibrotic skin of SSc patients, and reduction of experimental fibrosis…”
BackgroundInnate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
Laurent, P., Sisirak, V., Lazaro, E., Richez, C., Duffau, P., Blanco, P., Truchetet, M., & Contin‐Bordes, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01702 · Cited by 68
“The Distler group has shown that serotonin [5-hydroxytryptamine (5-HT)] stored in platelets strongly induces ECM synthesis in interstitial fibroblasts via activation of 5-HT2B receptors (5-HT2B) in a TGF-β-dependent manner (38).”
BackgroundNew therapeutic opportunities for 5-HT2 receptor ligands
Maroteaux, L., Ayme‐Dietrich, E., Aubertin-Kirch, G., Banas, S. M., Quentin, E., Lawson, R., & Monassier, L. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.008 · Cited by 66
Self-citationZhang, Y., Dees, C., Beyer, C., Lin, N.-Y., Distler, A., Zerr, P., Palumbo, K., Susok, L., Kreuter, A., Distler, O., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204256 · Cited by 64
Self-citationAiello, R. J., Bourassa, P.-A. K., Zhang, Q., Dubins, J. S., Goldberg, D. R., Lombaert, S. D., Humbert, M. J. C., Guignabert, C., Cavasin, M. A., McKinsey, T. A., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237933 · Cited by 63
“Several laboratories have linked platelet-derived 5-HT to pulmonary vascular disease, where others have suggested increased uptake and metabolism of 5-HT by the lung triggers development of idiopathic PAH (Dees et al., 2011).”
BackgroundNew insights on chemically induced animal models of systemic sclerosis
Batteux, F., Kavian, N., & Servettaz, A. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834b1606 · Cited by 62
Nieto, C., Rayo, I., Casas-Engel, M. D. L., Izquierdo, E., Alonso, B., Béchade, C., Maroteaux, L., Vega, M. A., & Corbí, A. L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901531 · Cited by 59
“in 5-HT–mediated pathologies like pulmonary arterial hypertension (10), dermal, lung and liver fibrosis (12, 29), cardiac hypertrophy (30), and valvular heart disease associated with carcinoid syndrome”
BackgroundSelf-citationInnovative antifibrotic therapies in systemic sclerosis
Beyer, C., Distler, O., & Distler, J. H. W. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283524b9a · Cited by 58
Self-citationChen, C., Han, X., Fan, F., Liu, Y., Wang, T., Wang, J., Hu, P., Ma, A., & Tian, H. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2194-0 · Cited by 58
“In addition, other studies showed that 5-HT increase the expression of collagen in many cells, such as mesangial cells, cardiac fibroblasts, and dermal fibroblasts [16, 29, 30].”
BackgroundNtelis, K., Solomou, E. E., Sakkas, L. I., Liossis, S. C., & Daoussis, D. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.05.004 · Cited by 58
Old medications and new targeted therapies in systemic sclerosis
Nagaraja, V., Denton, C. P., & Khanna, D. (2015) · Rheumatology · doi:10.1093/rheumatology/keu285 · Cited by 57
Cummings, H., Liu, T., Feng, C., Laidlaw, T. M., Conley, P. B., Kanaoka, Y., & Boyce, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302187 · Cited by 57
Faust, I., Traut, P., Nolting, F., Petschallies, J., Neumann, E., Kunisch, E., Kühn, J., Knabbe, C., & Hendig, D. (2015) · Scientific Reports · doi:10.1038/srep12537 · Cited by 55
Rouaud, A., Calder, A. E., & Hasler, G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811231225609 · Cited by 53
“If TGF-β signaling is not properly controlled in humans, it can lead to various cardiovascular diseases and vascular pathologies, including arteriovenous malformations, atherosclerosis, aneurysms, and valve fibrosis (Dees et al., 2011).”
Background5‐ HT 2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis
Kim, D. C., Jun, D. W., Kwon, Y. I., Lee, K. N., Lee, H. L., Lee, O. Y., Yoon, B. C., Choi, H. S., & Kim, E. K. (2013) · Liver International · doi:10.1111/liv.12110 · Cited by 53
“Similarly, skin fibrosis in systemic sclerosis patients has been found to be associated with 5-HT pathways (14).”
BackgroundTruchetet, M., Demoures, B., Guimaraes, J. E., Bertrand, A., Laurent, P., Jolivel, V., Douchet, I., Jacquemin, C., Khoryati, L., Duffau, P., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39817 · Cited by 53
“Among the IL-1b–secreting cells activated in SSc patients, platelets were of significant interest (10,24).”
BackgroundInfluentialJagadapillai, R., Rane, M. J., Lin, X., Roberts, A. M., Hoyle, G. W., Cai, L., & Gozal, E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111853 · Cited by 52
“Recent studies in mice and other animal models of diabetes showed that platelets increase alveolar capillary permeability and identified serotonin from platelets as a mediator that links vascular damage to extravascular tissue fibrosis [59].”
BackgroundPark, J.-S., Oh, Y., Park, Y. J., Park, O., Yang, H. S., Slania, S., Hummers, L. K., Shah, A. A., An, H.-T., Jang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09101-4 · Cited by 52
Targeted therapies for systemic sclerosis
Denton, C. P., & Ong, V. H. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.46 · Cited by 52
The role of platelets in the pathogenesis of systemic sclerosis
Ramirez, G. A., Franchini, S., Rovere, P. Q., Sabbadini, M. G., Manfredi, A. A., & Maugeri, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00160 · Cited by 51
“Moreover platelet-derived serotonin has recently been linked to the development of fibrosis (Dees et al., 2011; see below).”
BackgroundInfluentialAnimal models of systemic sclerosis: their utility and limitations
Artlett, C. M. (2014) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s50009 · Cited by 50
Peripheral serotonin regulates postoperative intra-abdominal adhesion formation in mice
Bi, J., Zhang, S., Du, Z., Zhang, J., Deng, Y., Liu, C., & Zhang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-10582-w · Cited by 50
Misunderstandings Between Platelets and Neutrophils Build in Chronic Inflammation
Ramirez, G. A., Manfredi, A. A., & Maugeri, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02491 · Cited by 50
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis
Manetti, M., Guiducci, S., Romano, E., Rosa, I., Ceccarelli, C., Mello, T., Milia, A. F., Conforti, M. L., Ibba‐Manneschi, L., & Matucci‐Cerinic, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37712 · Cited by 50
“Localization of JAMs at nonjunctional sites of activated/ injured ECs may also facilitate the adhesion of platelets (18), which have been implicated in SSc pathogenesis via the release of bioactive molecules that regulate inflammation, angiogenesis, and ECM synthesis (3,40).”
Ayme‐Dietrich, E., Lawson, R., Côté, F., de Tapia, C., Silva, S. D., Ebel, C., Hechler, B., Gachet, C., Guyonnet, J., Rouillard, H., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13981 · Cited by 49
“BJP E Ayme-Dietrich et al. 4130 British Journal of Pharmacology (2017) 174 4123–4139 reduces dermal fibrosis in models where a contribution from platelet 5-HT is highly likely (Dees et al., 2011).”
BackgroundSelf-citationCardiomyopathy in Murine Models of Systemic Sclerosis
Venalis, P., Kumánovics, G., Schulze‐Koops, H., Distler, A., Dees, C., Zerr, P., Palumbo‐Zerr, K., Czirják, L., Mackevic, Z., Lundberg, I. E., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38942 · Cited by 49
Self-citationTextor, J. A. (2013) · Lecture notes in bioengineering · doi:10.1007/978-3-642-40117-6_2 · Cited by 47
“Platelets also directly contribute to the formation of new tissue, from ovulation (Furukawa et al. 2007) to embyogenesis (Finney et al. 2012) to maturity, (Olorundare et al. 2001) in both health and disease (Luttenberger et al. 2000; Dees et al. 2011).”
BackgroundInfluentialVascular Remodelling and Mesenchymal Transition in Systemic Sclerosis
Nicolosi, P. A., Tombetti, E., Maugeri, N., Rovere, P. Q., Brunelli, S., & Manfredi, A. A. (2016) · Stem Cells International · doi:10.1155/2016/4636859 · Cited by 47
“Moreover they generate and release an array of profibrotic signals, including transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), and serotonin [15].”
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis
Krönke, G., Reich, N., Scholtysek, C., Akhmetshina, A., Uderhardt, S., Zerr, P., Palumbo, K., Lang, V. R., Dees, C., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200745 · Cited by 46
Self-citationYan, D., Liu, X., Xu, H., & Guo, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa550 · Cited by 45
The complex regulation of TGF-ß in cardiovascular disease
Redondo, S., Navarro‐Dorado, J., Ramajo, M., Medina, Ú., & Tejerina, T. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s28041 · Cited by 45
“62 However, in late stages of the disease, TGF-β 1 seems to behave as a proatherogenic factor by increasing excessive extracellular matrix, 63 promotion of in-stent restenosis, 64 and induction of pathologic vascular remodeling.”
Metadata
- Authors
- Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., Reiter, R., Alenina, N., Maroteaux, L., Gay, S., Schett, G., Distler, O., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Zurich (CH)
- ErgoNex Pharma GmbH, CH-9050 Appenzell, Switzerland 3
- Max Delbrück Center (DE)
- Inserm (FR)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-04-25
- Volume
- 208
- Issue
- 5
- Pages
- 961-972
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3092343
- OpenAlex
- W2025287936
- Cited by
- 266
- References
- 63
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 22 · 2020: 22 · 2019: 14 · 2018: 22 · 2017: 12 · 2016: 20 · 2015: 16 · 2014: 21 · 2013: 21 · 2012: 37
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- serotonin, platelets, 5-HT2B receptor, skin fibrosis, systemic sclerosis, extracellular matrix synthesis, fibroblasts, TGF-beta signaling, platelet activation, vascular injury, tissue remodeling, tryptophan hydroxylase 1, therapeutic target
- MeSH terms
- Animals, Blood Platelets, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Scleroderma, Systemic, Serotonin, Signal Transduction, Platelet Activation, Transforming Growth Factor beta, Mice, Knockout, Receptor, Serotonin, 5-HT2B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.